Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance

In about five years India’s population will exceed that of China which is currently ranked number one according to population. Contrast these numbers with the fact that only ten percent…

Continue Reading Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance

Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment

For years FibroGen has been investigating a drug called pamrevlumab. They believe it could be an effective treatment for Duchenne muscular dystrophy (DMD), pancreatic cancer, and idiopathic pulmonary fibrosis (IPF).…

Continue Reading Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment
Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments
rawpixel / Pixabay

Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

According to a story from CRWE World, the genetic medicines company Audentes Therapeutics has recently announced its intent to develop new therapies for myotonic dystrophy and Duchenne muscular dystrophy. These…

Continue Reading Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU

According to a story from Market Screener, the specialty pharmaceutical company Santhera Pharmaceuticals recently released an announcement in which the company revealed its intent to file for Conditional Marketing Authorization…

Continue Reading Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU
CRISPR Successfully Treats Duchenne Muscular Dystrophy in Mouse Model
Alexas_Fotos / Pixabay

CRISPR Successfully Treats Duchenne Muscular Dystrophy in Mouse Model

According to a story from Fierce Biotech, the results of a year-long study examining the utility of the groundbreaking gene-editing technology CRISPR in treating the rare genetic disorder Duchenne muscular…

Continue Reading CRISPR Successfully Treats Duchenne Muscular Dystrophy in Mouse Model
Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits
allinonemovie / Pixabay

Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits

According to a story from BBC, Mats Steen passed away at 25 years old due to complications from his Duchenne muscular dystrophy. Upon his death, parents Robert and Trude grieved…

Continue Reading Online Gaming Allowed Duchenne Muscular Dystrophy Patient to Transcend Physical Limits
New Funding Program to Support Newborn Screening for Duchenne Muscular Dystrophy
Source: Pixabay

New Funding Program to Support Newborn Screening for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a rare, progressive, and fatal condition. It primarily affects males (1 out of every 3,600 to 6,000 male births). It's caused by…

Continue Reading New Funding Program to Support Newborn Screening for Duchenne Muscular Dystrophy
Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial
PhotoLizM / Pixabay

Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial

According to a story from pm360online.com, the life sciences company Solid Biosciences has released some preliminary findings from its Phase 1/2 clinical trial of SGT-001. This investigational product is in…

Continue Reading Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial
New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma
felixioncool / Pixabay

New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma

According to a story from bioengineer.org, it has long been known that people with the rare disorder Duchenne muscular dystrophy are at a greater risk of developing a rare cancer…

Continue Reading New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma

Australian Government Initiates New Trial Program to Support Individuals Recently Diagnosed with a Rare Disease

Being diagnosed with any serious condition can be scary, overwhelming, and full of unknowns. For those who are diagnosed with a rare disease such as Duchenne muscular dystrophy, spinal muscular atrophy,…

Continue Reading Australian Government Initiates New Trial Program to Support Individuals Recently Diagnosed with a Rare Disease
Company Provides Updates for Phase 3 Duchenne Muscular Dystrophy Trial
Aymanejed / Pixabay

Company Provides Updates for Phase 3 Duchenne Muscular Dystrophy Trial

According to a story from drugs.com, the biopharmaceutical company Catabasis pharmaceuticals recently provided updates on the status of its Phase 3 clinical trial testing its investigational therapy CAT-1004, also known…

Continue Reading Company Provides Updates for Phase 3 Duchenne Muscular Dystrophy Trial
ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial
931527 / Pixabay

ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial

According to a story from globenewswire.com, the biotechnology company Wave Life Sciences Ltd. recently announced that the tolerability and safety data from its Phase 1 clinical trial of its investigational therapy…

Continue Reading ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial
Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
Myriams-Fotos / Pixabay

Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients

According to a story from EurekAlert!, monitoring lung function is an important role of managing Duchenne muscular dystrophy and other diseases that can cause wasting of the respiratory muscles. Many…

Continue Reading Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
Man With Duchenne Muscular Dystrophy Celebrates 50th Birthday After Grim Prognosis as a Child
source: pixabay.com

Man With Duchenne Muscular Dystrophy Celebrates 50th Birthday After Grim Prognosis as a Child

  Andrew Taylor celebrated his 50th birthday this year. This is a big year for anyone, but especially for Taylor, who was told he would not make it to the…

Continue Reading Man With Duchenne Muscular Dystrophy Celebrates 50th Birthday After Grim Prognosis as a Child
The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy
Source: Pixabay.com

The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy

This past Sunday, December 2nd, during the Patriot's game against the Minnesota Vikings, 20 players wore customized cleats to spread awareness for various philanthropic causes. This is the third year…

Continue Reading The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy
A Clinical Trial for Gene Therapy is Underway for Muscular Dystrophy!
https://pixabay.com/en/forms-tax-return-additional-expenses-2004856/

A Clinical Trial for Gene Therapy is Underway for Muscular Dystrophy!

Limb-Girdle Muscular Dystrophy or LGMD, is a form of Muscular Dystrophy caused by a mutation which disrupts production of the protein beta-sarcoglycan. There are currently no treatment options for LGMD and…

Continue Reading A Clinical Trial for Gene Therapy is Underway for Muscular Dystrophy!
Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
source: pixabay.com

Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media

According to a story from nature.com, Amber Sapp's twelve year old son Garrett had been participating in a clinical trial that was testing a new potential treatment for his Duchenne…

Continue Reading Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
Patient Registry Demonstrates The Effectiveness of Translarna in Duchenne Muscular Dystrophy
suc / Pixabay

Patient Registry Demonstrates The Effectiveness of Translarna in Duchenne Muscular Dystrophy

According to a story from prnewswire.co.uk, the biopharmaceutical company PTC Therapeutics recently announced the release of initial data from the first drug registry for its product Translarna (ataluren). This registry…

Continue Reading Patient Registry Demonstrates The Effectiveness of Translarna in Duchenne Muscular Dystrophy
A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
harshahars / Pixabay

A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?

According to a story from Boston Health News, The US Food and Drug Administration's Accelerated Approval program is being used to approve a steadily growing number of drugs in recent…

Continue Reading A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?

Clinical Trial for Duchenne Muscular Dystrophy Gene Therapy Restarts After Hold Lifted

According to a story from statnews.com, the drug developer Sarepta has recently announced the its clinical trial testing an experimental gene therapy has resumed after the FDA lifted the hold.…

Continue Reading Clinical Trial for Duchenne Muscular Dystrophy Gene Therapy Restarts After Hold Lifted